Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of AGM & Posting of Annual Report

29th May 2026 14:00

RNS Number : 2877G
Diaceutics PLC
29 May 2026
 

Diaceutics PLC

 

Notice of AGM and Posting of Annual Report

 

New York, Belfast and London, 29 May 2026 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that it has today posted its Annual Report for the year ended 31 December 2025 to shareholders together with the Notice of the 2026 Annual General Meeting ("AGM").

 

The Company will hold its AGM on Thursday, 25 June 2026 at 10.30am at First Floor, Building Two, Dataworks at Kings Hall Health and Wellbeing Park, Belfast, County Antrim BT9 6GW.

 

The Annual Report and Notice of AGM will also be available shortly on the Company's website at www.diaceutics.com

 

Enquiries: 

Diaceutics PLC 

Ryan Keeling, Chief Executive Officer  

Nick Roberts, Chief Financial Officer 

Tel: +44 (0)28 9040 6500

[email protected]

 

Canaccord Genuity Limited (Nomad & Broker) 

Tel: +44 (0)20 7523 8000

Simon Bridges, Andrew Potts, Harry Rees

 

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAFLFVFEFIAFIR

Related Shares:

Diaceutics
FTSE 100 Latest
Value10,338.95
Change-70.33